Peregrine Pharmaceuticals traded at $17.66 this Tuesday August 9th, decreasing $0.84 or 4.54 percent since the previous trading session. Looking back, over the last four weeks, Peregrine Pharmaceuticals lost 0.34 percent. Over the last 12 months, its price fell by 37.64 percent. Looking ahead, we forecast Peregrine Pharmaceuticals to be priced at 18.82 by the end of this quarter and at 17.30 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Agenus 2.56 -0.05 -1.92% -54.37%
Amgen 248.36 1.07 0.43% 8.95%
AstraZeneca 10,818.00 -24.00 -0.22% 32.75%
BioCryst Pharmaceuticals 14.45 0.24 1.69% -4.97%
Bristol-Myers Squibb 74.96 1.16 1.57% 12.10%
ChemoCentryx 50.79 -0.10 -0.20% 254.93%
Celldex Therapeutics 35.28 -2.19 -5.84% -24.13%
GlaxoSmithKline 1,639.30 -7.50 -0.46% 13.37%
Immunogen 5.27 -0.12 -2.23% -6.23%
Karyopharm Therapeutics 4.91 -0.25 -4.85% -11.37%
Eli Lilly 303.02 0.52 0.17% 14.74%
MacroGenics 5.10 0.55 12.09% -79.24%
MannKind 4.09 -0.26 -5.98% 5.14%
Merck & Co 89.52 1.03 1.16% 19.06%
Minerva Neurosciences 3.60 -1.13 -23.89% 126.42%
Lumos Pharma Inc. 8.10 -0.45 -5.26% 9.02%
Novartis 83.31 0.05 0.06% -1.77%
Novavax 40.28 -16.97 -29.64% -82.50%
Peregrine Pharmaceuticals 17.66 -0.84 -4.54% -37.64%
Repligen 244.85 -5.61 -2.24% -2.11%
Roche Holding 316.65 -1.70 -0.53% -13.21%
Xencor 29.21 -0.20 -0.68% -7.53%
Intrexon 2.31 0.26 12.68% -61.76%

Indexes Price Day Year
USND 12494 -150.53 -1.19% -15.51%
US2000 1913 -28.31 -1.46% -14.58%

Peregrine Pharmaceuticals
Avid Bioservices, Inc. is a contract development and manufacturing organization (CDMO). The Company is focused on development and Current Good Manufacturing Practices (CGMP) manufacturing of biopharmaceutical products derived from mammalian cell culture. The Company provides a range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. The Company’s services include CGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The Company also provides process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization.